These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27889768)

  • 21. Serum cystatin C advantageous compared with serum creatinine in the detection of mild but not severe diabetic nephropathy.
    Christensson AG; Grubb AO; Nilsson JA; Norrgren K; Sterner G; Sundkvist G
    J Intern Med; 2004 Dec; 256(6):510-8. PubMed ID: 15554952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary podocalyxin positive-element occurs in the early stage of diabetic nephropathy and is correlated with a clinical diagnosis of diabetic nephropathy.
    Ye H; Bai X; Gao H; Li L; Wu C; Sun X; Zhang C; Shen Y; Zhang J; Lu Z
    J Diabetes Complications; 2014; 28(1):96-100. PubMed ID: 24075693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ability of cystatin C to detect acute changes in glomerular filtration rate provoked by hyperglycaemia in uncomplicated Type 1 diabetes.
    Cherney DZ; Sochett EB; Dekker MG; Perkins BA
    Diabet Med; 2010 Dec; 27(12):1358-65. PubMed ID: 21059087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NGAL and cystatin C: two possible early markers of diabetic nephropathy in young patients with type 1 diabetes mellitus: one year follow up.
    Papadopoulou-Marketou N; Skevaki C; Kosteria I; Peppa M; Chrousos GP; Papassotiriou I; Kanaka-Gantenbein C
    Hormones (Athens); 2015; 14(2):232-40. PubMed ID: 25402375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is cystatin C a useful marker in the detection of diabetic kidney disease?
    Borges RL; Hirota AH; Quinto BM; Ribeiro AB; Zanella MT; Batista MC
    Nephron Clin Pract; 2010; 114(2):c127-34. PubMed ID: 19887833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mendelian randomization study supports the causal association between serum cystatin C and risk of diabetic nephropathy.
    Feng B; Lu Y; Ye L; Yin L; Zhou Y; Chen A
    Front Endocrinol (Lausanne); 2022; 13():1043174. PubMed ID: 36482996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteoinductive factor is a novel biomarker for the diagnosis of early diabetic nephropathy.
    Wang S; Wang Y; Zheng R; Zhao Z; Ma Y
    Int J Clin Exp Pathol; 2015; 8(3):3110-5. PubMed ID: 26045825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of cystatin C- and creatinine-based estimated glomerular filtration rate to predict coronary heart disease risk in Japanese patients with obesity and diabetes.
    Ito R; Yamakage H; Kotani K; Wada H; Otani S; Yonezawa K; Ogo A; Okajima T; Adachi M; Araki R; Yoshida K; Saito M; Nagaoka T; Toyonaga T; Tanaka T; Yamada T; Ota I; Oishi M; Miyanaga F; Shimatsu A; Satoh-Asahara N;
    Endocr J; 2015; 62(2):201-7. PubMed ID: 25399862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preprocedure and Postprocedure Predictive Values of Serum β2-Microglobulin for Contrast-Induced Nephropathy in Patients Undergoing Coronary Computed Tomography Angiography: A Comparison With Creatinine-Based Parameters and Cystatin C.
    Li S; Zheng Z; Tang X; Peng L; Luo Y; Dong R; Zhao Y; Liu J
    J Comput Assist Tomogr; 2015; 39(6):969-74. PubMed ID: 26248154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients.
    Mussap M; Dalla Vestra M; Fioretto P; Saller A; Varagnolo M; Nosadini R; Plebani M
    Kidney Int; 2002 Apr; 61(4):1453-61. PubMed ID: 11918752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum cystatin C may predict the early prognostic stages of patients with type 2 diabetic nephropathy.
    Shimizu A; Horikoshi S; Rinnno H; Kobata M; Saito K; Tomino Y
    J Clin Lab Anal; 2003; 17(5):164-7. PubMed ID: 12938144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal biopsy in patients with diabetes: a pooled meta-analysis of 48 studies.
    Fiorentino M; Bolignano D; Tesar V; Pisano A; Biesen WV; Tripepi G; D'Arrigo G; Gesualdo L;
    Nephrol Dial Transplant; 2017 Jan; 32(1):97-110. PubMed ID: 27190327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Salivary and serum cystatin SA levels in patients with type 2 diabetes mellitus or diabetic nephropathy.
    Techatanawat S; Surarit R; Chairatvit K; Roytrakul S; Khovidhunkit W; Thanakun S; Izumi Y; Khovidhunkit SP
    Arch Oral Biol; 2019 Aug; 104():67-75. PubMed ID: 31174096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association Between Matrix Metalloproteinase-3 Activity and Glomerular Filtration Rate and Albuminuria Status in Patients With Type 2 Diabetes Mellitus.
    Amanzadeh M; Mota A; Zarghami N; Abedi-Azar S; Abroon S; Akbarian N; Mihanfar A; Rahmati-Yamchi M
    Iran J Kidney Dis; 2018 Jan; 12(1):40-47. PubMed ID: 29421776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive power of serum cystatin C to detect acute kidney injury and pediatric-modified RIFLE class in children undergoing cardiac surgery.
    Hassinger AB; Backer CL; Lane JC; Haymond S; Wang D; Wald EL
    Pediatr Crit Care Med; 2012 Jul; 13(4):435-40. PubMed ID: 22596066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta2-microglobulin and cystatin C in type 2 diabetes: assessment of diabetic nephropathy.
    Aksun SA; Ozmen D; Ozmen B; Parildar Z; Mutaf I; Turgan N; Habif S; Kumanlioğluc K; Bayindir O
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):195-200. PubMed ID: 15127324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of kidney function in diabetic patients. Is there a role for new biomarkers NGAL, cystatin C and KIM-1?
    Matys U; Bachorzewska-Gajewska H; Malyszko J; Dobrzycki S
    Adv Med Sci; 2013; 58(2):353-61. PubMed ID: 24384771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic Accuracy of Neutrophil Gelatinase-Associated Lipocalin for Predicting Early Diabetic Nephropathy in Patients with Type 1 and Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis.
    Kapoula GV; Kontou PI; Bagos PG
    J Appl Lab Med; 2019 Jul; 4(1):78-94. PubMed ID: 31639710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accuracy of hematuria for predicting non-diabetic renal disease in patients with diabetes and kidney disease: A systematic review and meta-analysis.
    Jiang S; Wang Y; Zhang Z; Dai P; Yang Y; Li W
    Diabetes Res Clin Pract; 2018 Sep; 143():288-300. PubMed ID: 30059756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus.
    Awadallah SM; Saleh SA; Abu Shaqra QM; Hilow H
    J Diabetes Complications; 2008; 22(6):384-8. PubMed ID: 18413152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.